---
title: Bioventus CEO cites SmartTRAK HA Market Stats in Durolane Approval
description: Citing SmartTRAK data, Bioventus CEO Tony Bihl said in an email that “the 2016 entire HA market in the US (1-shot, 2-shot, 3-shot and 5-shot) was about $979M.”
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [Bioventus CEO cites SmartTRAK HA Market Stats in Durolane Approval](https://blog.smarttrak.com/bioventus-ceo-tony-bihl-cites-smarttrak-ha-market-stats-in-durolane-approval)

 Written by [Rebecca Gonzalez](https://blog.smarttrak.com/author/rebecca-gonzalez) | 9/10/17 1:00 PM

Durham-based Bioventus has received approval from the U.S. Food and Drug Administration for its treatment, Durolane.

The single-injection product treats knee osteoarthritis pain. The company plans to launch Durolane in the U.S. early next year.

Citing **BioMedGPS SmartTRAK**, Bioventus CEO Tony Bihl said in an email that “the 2016 entire HA market in the US (1-shot, 2-shot, 3-shot and 5-shot) was about $979 million.”

Durham-based Bioventus CEO Tony Bihl

Read the story [by Jennifer Henderson at Triangle Business Journal](https://www.bizjournals.com/triangle/news/2017/09/06/durham-pharma-receives-fda-approval.html)...

Read the Bioventus Press Release [Bioventus Receives US FDA Approval for DUROLANE®](https://www.bioventusglobal.com/bioventus-receives-us-fda-approval-durolane/).

[View full post](https://blog.smarttrak.com/bioventus-ceo-tony-bihl-cites-smarttrak-ha-market-stats-in-durolane-approval)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Rebecca Gonzalez"
  },
  "dateModified" : "2017-09-11T01:14:23.851Z",
  "datePublished" : "2017-09-10T13:00:00Z",
  "headline" : "Bioventus CEO cites SmartTRAK HA Market Stats in Durolane Approval",
  "image" : {
    "@type" : "ImageObject",
    "height" : 339,
    "url" : "https://cdn2.hubspot.net/hubfs/3044256/Durham-based%20Bioventus%20CEO%20Tony%20Bihl.png",
    "width" : 257
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/bioventus-ceo-tony-bihl-cites-smarttrak-ha-market-stats-in-durolane-approval",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```